Pharma Science

Looking for new and improved technologies to advance your peptide mapping strategies? Do you want to overcome automation problems with your therapeutic protein workflows? If so, signup for this educational presentation...

Rapid development of sensitive and selective peptide bioanalytical methods are required to support the expanding protein component of pharmaceutical companies’ drug pipeline. Choosing the best MRM for a large molecule peptide or protein is a...

Learn how to assure data integrity in the laboratory from the perspective of laboratory management, supervisors and technicians.

There is currently a great deal of regulatory focus on data integrity, especially in the QC Laboratory. This is...

Extractables and leachables (E&Ls) are small molecules present in a polymer system including antioxidants, surfactants, slip agents, plasticizers, acid scavengers, cross linking agents, residual monomers and oligomers, polymerization side...

Recombinant biopharmaceutical proteins are expressed in host cell systems that contain numerous host cell proteins (HCPs). Even after a series of purifications, low levels of HCPs can remain in the purified biotherapeutics, which could reduce...

Peptide mapping is vital to understanding the structure of proteins and monitoring critical quality attributes. To create effective, high-quality biotherapeutics, you have to get this right. Renowned for accuracy and reliability, Agilent offers a...

The presentation summarizes the latest updates for the analysis of biopharmaceuticals using the Agilent 1290 Infinity II 2D-LC Solution. After a short introduction to the principle mode of operation, I will explain the latest 2D-LC modes;...

Routine analysis of therapeutic protein N-glycosylation has become important in biopharma discovery, development and QC labs. This presentation will briefly review recent advances in automated sample preparation and ultra-high performance HILIC...

Biotherapeutics – recombinant proteins, such as monoclonal antibodies – are highly complex molecules produced by fermentation. Unlike small molecule drugs they can contain numerous sites of heterogeneity as well as other impurities (which can...

Want to know more about new methods for biotherapeutics analysis? Looking to streamline your bioprocess workflows? Need help with your data quality? If so, then this on-demand event is for you...

Polymeric and other content can contribute up to 90% of the total mass in a pharmaceutical product, where excipients play a critical role in the drug’s performance. In just one example of the importance of excipient properties for therapeutic...

Looking to improve the yield and purity of your target proteins? Then don't miss this on-demand presentation...